Small Molecules Therapeutic Area

Australia is ideally positioned to be a major player in the global Pharma ecosystem where risk-averse companies are looking to in-licence assets that have demonstrated development potential.

Therefore, to enhance the progression of early stage discoveries through to preclinical development, TIA has formed a Small Molecules Group which is an integrated capability network of National Research Infrastructure across Australia. These facilities are committed to provide high quality research infrastructure to support leading‑edge research and to boost innovation in Australia.

Capabilities/Services offered  >

Compounds Australia


Pipeline Accelerator

Support for screening projects
Capabilities/Services offered  >

Australian Translational Medicinal Chemistry Facility 

Capabilities/Services offered  >

Centre for Drug Candidate Optimisation

Capabilities/Services offered  >

Centre for Integrated Preclinical Drug Development

Capabilities/Services offered  >


TetraQ logo_b.jpg

Level 14, 330 Collins St

Melbourne 3000 VIC


T: +61 (07) 3735 4433

©2019 Therapeutic Innovation Australia


Enabled by